Table 4. Effect of carvedilol on galectin-3 and myeloperoxidase.
Placebo | Carvedilol | P value | |
---|---|---|---|
N = 148 | N = 26 | ||
Galectin 3 ng/ml | 0.32 | ||
Baseline | 6.3 (5.2–9.2) | 6.4 (5.1, 10.8) | |
12 weeks | 11.8 (10.2–15.9) | 12.9 (9.1, 16.2) | |
24 weeks | 11.2 (8.4–12.8) | 10.3 (7.5–13.1) | |
Myeloperoxidase ng/ml | 0.28 | ||
Baseline | 13.3 (7.6–21.0) | 13.2 (8.5–29.2) | |
12 weeks | 15.3 (11.0–25.5) | 20.9 (11.2–39.1) | |
24 weeks | 19.6 (11.9–37.7) | 19.2 (10.6–43.7) |